Was looking at this to buy but then checked their numbers from their half yearly - $6M burn including startup costs and a $450K loss on contract price so far. Wages and Mtce on the rigs not accounted for accurately??? No receivables listed. Introductory contract offers will be over now, will be an interesting ride. BTW I'm only got my L plates with this so happy to be corrected.
- Forums
- ASX - By Stock
- VYS
- News: VYS Vysarn Expects Full Year EBITDA To 30 June Will Be About $5.90M
News: VYS Vysarn Expects Full Year EBITDA To 30 June Will Be About $5.90M, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
Add VYS (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $133.9M |
Open | High | Low | Value | Volume |
32.0¢ | 32.5¢ | 32.0¢ | $28.93K | 90.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1290 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 48739 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 21261 | 0.315 |
5 | 184000 | 0.310 |
2 | 13114 | 0.305 |
1 | 35000 | 0.300 |
2 | 107389 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 48739 | 1 |
0.330 | 100000 | 1 |
0.335 | 13548 | 1 |
0.340 | 122239 | 6 |
0.345 | 100000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
VYS (ASX) Chart |